Bagley D M, Cerven D, Harbell J
Colgate-Palmolive Company, 909 River Road, Piscataway, NJ 08855, USA.
Toxicol In Vitro. 1999 Apr;13(2):285-93. doi: 10.1016/s0887-2333(98)00089-7.
The chorioallantoic membrane vascular assay (CAMVA) is an alternative to the Draize rabbit eye irritation method. The CAMVA employs the vascularized membrane of a fertile hen's egg to assess eye irritation potential. This irritation potential is a function of alterations in the vasculature following the administration of test material. Because of the history of use of the CAMVA it was selected as one of the methods for a validation study organized and sponsored by COLIPA. For this validation study mathematical prediction models (PMs) were developed to convert the CAMVA results into predicted Draize eye irritation scores known as a modified maximum average Draize score (MMAS). These predicted scores were statistically compared with the observed scores to assess the relevance of the CAMVA. The assay was conducted on the same set of test materials by two independent laboratories. These two sets of data were compared to assess the interlaboratory reproducibility of the assay. The results of this validation study of the CAMVA show that for test materials with MMASs in the 0 to 5 range or the 55 to 110 range, the CAMVA did not give a good prediction. The predictions were better for samples of mild to moderate irritation (MMAS 5-55). The difficulty in predicting at the low end of the irritation scale appears to be due to the biological variability of the test system and the subjective nature of the CAMVA evaluation. For those samples with an MMAS above 55, the CAMVA appeared to be limited in demonstrating the more severe response. This may be due to the fact that the PMs were developed using historical data sets of test materials with MMASs below this range. Two approaches for improving the CAMVA for eye irritation prediction are (1) to decrease the variability at the low end by reducing the subjectivity in the scoring and (2) to develop better prediction models using more data in the range of severe irritants.
绒毛尿囊膜血管试验(CAMVA)是兔眼Draize刺激试验方法的替代方法。CAMVA利用受精鸡蛋的血管化膜来评估眼刺激潜力。这种刺激潜力是给药后脉管系统变化的函数。由于CAMVA的使用历史,它被选为欧洲化妆品、个人护理用品和香水协会(COLIPA)组织和赞助的验证研究方法之一。在该验证研究中,开发了数学预测模型(PMs),将CAMVA结果转换为预测的Draize眼刺激评分,即修正的最大平均Draize评分(MMAS)。将这些预测评分与观察到的评分进行统计学比较,以评估CAMVA的相关性。两个独立实验室对同一组测试材料进行了该试验。比较这两组数据以评估该试验的实验室间重现性。CAMVA验证研究的结果表明,对于MMAS在0至5范围或55至110范围的测试材料,CAMVA的预测效果不佳。对于轻度至中度刺激的样品(MMAS 5 - 55),预测效果较好。在刺激量表低端进行预测的困难似乎是由于测试系统的生物学变异性和CAMVA评估的主观性。对于MMAS高于55的那些样品,CAMVA在显示更严重反应方面似乎受到限制。这可能是由于PMs是使用MMAS低于此范围的测试材料的历史数据集开发的。改进CAMVA用于眼刺激预测的两种方法是:(1)通过减少评分中的主观性来降低低端的变异性;(2)使用更多严重刺激物范围内的数据开发更好的预测模型。